Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Kadimastem Announces the Completion of Cell Transplantation of AstroRx in ALS Patients

americanpharmaceuticalreviewFebruary 28, 2019

Tag: Kadimastem , cell transplantation , AstroRx , ALS

PharmaSources Customer Service